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Abstract: The goal of this study was to determine if impairments detected by the test of 
variables of attention (TOVA) may be used to predict early attention complaints and memory 
impairments accurately in a clinical setting. We performed a statistical analysis of outcomes in 
a patient population screened for attention deficit hyperactivity disorder or attention complaints, 
processing errors as measured by TOVA and the Wechsler Memory Scale (WMS-III) results. 
Attention deficit disorder (ADD) checklists, constructed using the Diagnostic and Statistical 
Manual of Mental Disorders 4th Edition criteria, which were completed by patients at PATH 
Medical, revealed that 72.8% of the patients had more than one attention complaint out of a total 
of 16 complaints, and 41.5% had more than five complaints. For the 128 males with a significant 
number of ADD complaints, individuals whose scores were significantly deviant or borderline 
(SDB) on TOVA, had a significantly greater number of attention complaints compared with 
normals for omissions (P , 0.02), response time (P , 0.015), and variability (P , 0.005), but 
not commissions (P . 0.50). For males, the mean scores for auditory, visual, immediate, and 
working memory scores as measured by the WMS-III were significantly greater for normals 
versus SDBs on the TOVA subtest, ie, omission (P , 0.01) and response time (P , 0.05), but 
not variability or commissions. The means for auditory, visual, and immediate memory scores 
were significantly greater for normals versus SDBs for variability (P , 0.045) only. In females, 
the mean scores for visual and working memory scores were significantly greater for normals 
versus SDBs for omissions (P , 0.025). The number of SDB TOVA quarters was a significant 
predictor for “impaired” or “normal” group membership for visual memory (P , 0.015), but 
not for the other three WMS-III components. For males, the partial correlation between the 
number of attention complaints and the number of SDB TOVA quarters was also significant 
(r = 0.251, P , 0.005). For the 152 females with a significant number of attention complaints, 
no significant differences between SDBs and normals were observed (P . 0.15). This is the 
first report, to our knowledge, which provides evidence that TOVA is an accurate predictor of 
early attention complaints and memory impairments in a clinical setting. This finding is more 
robust for males than for females between the ages of 40 and 90 years.
Keywords: attention complaints, dementia, TOVA, Wechsler Memory Scale
Introduction
This study suggests that the test of variables of attention (TOVA), a continuous per-
formance test used to measure the speed and accuracy of attentional processing,1 may 
correlate with memory impairments as measured by certain memory tests, such as 
the Wechsler Memory Scale (WMS-III)2 and early attention complaints selected from 
the Diagnostic and Statistical Manual of Mental Disorders 4th Edition (DSM-IV) in 
a clinical setting. It is a follow-up to our previous work on declines in neurological 
processing speed and correlations with TOVA errors.3
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Attention deficit hyperactivity disorder (ADHD), a com-
mon disorder among children, is a neuropsychiatric disorder 
characterized by symptoms of inattention, impulsivity, psy-
chomotor delays, and hyperactivity. Some studies estimate 
that 3%–4% of the adult population have symptoms of ADHD. 
More importantly, a much larger percentage of adults have 
attention complaints, ie, they meet some of the DSM-IV cri-
teria for attention deficit disorder (ADD)/ADHD but do not 
have ADD/ADHD with and without comorbid psychiatric 
disorders. This population is the focus of our investigation.4
Attention problems have a multimodal dimension. 
ADHD, including attention complaints, is related to memory, 
as well as neuroelectrophysiologic and psychiatric factors. 
Attention complaints also have advanced psychiatric disease 
(Axis I) sources (DSM-IV), such as anxiety disorders, depres-
sion, and schizophrenia.5 Sometimes the sources of attention 
problems include variations in intelligence quotient.6 There 
is also a well documented genetic component to ADHD. Up 
to this point, research has identified genetic associations with 
candidate genes from known biologic pathways.7
TOVA has been successfully used to diagnose ADHD and 
its many subtypes.8–12 These subtypes include pure inattention, 
impulsivity, attentional failure due to depression or psycho-
motor retardation, and inconsistency. Each of these four cate-
gories correlates with a TOVA error subscale. The TOVA will 
be described in more detail in the methods section, but for the 
purposes of this discussion, the four subtypes of TOVA errors 
will be generalized here as follows: omission errors occurring 
when the patient fails to respond to the appropriate stimulus; 
commission errors occurring when the patient responds to 
an inappropriate stimulus; slowed reaction time occurring 
when there is an unusually long delay in response time after 
the appropriate stimulus is displayed; and response time vari-
ability as a measure of the consistency between all response 
times for the patient. In terms of describing the subtypes of 
ADHD, pure inattention correlates with omission errors on 
the TOVA, impulsivity correlates with commission errors, 
psychomotor retardation correlates with slowed reaction time, 
and inconsistency correlates with high variability in response 
time on the TOVA.
Interestingly, diagnoses of ADHD are becoming increas-
ingly prevalent among the adult population, and have been 
designated “adult ADD” (AADD), although there are some 
differences, including a less pronounced or absent hyperac-
tivity component.13,14 AADD is recognized as a disability 
under US federal legislation, including the Rehabilitation Act 
of 1973 and the Americans with Disabilities Act (National 
Institutes of Health).
The high prevalence of AADD and attention complaints is 
manifested in accidental injury statistics. In 2004 there were 
over 112,000 deaths due to such injuries, which are by their 
very nature tied to issues of attention.15 From an employer’s 
point of view, such accidents and other forms of risk to self 
and others incur high human capital costs. Adequate diag-
nosis and treatment would lead to greater productivity.16 The 
increasing need for early recognition and understanding of 
these problems prompted our present investigation.
Our earlier work involved correlation of increased P300 
brain wave latency (a measure of neurologic processing 
speed that may be used to measure cognitive decline) with 
abnormalities on the TOVA.3 As a follow-up to our findings, 
we performed a statistical analysis to correlate outcomes on 
the TOVA with a modified DSM-IV screening tool (attention 
complaints), with additional correlations made with memory 
function as determined by the WMS-III. We intended to 
determine the utility of TOVA in ADD recognition, and to 
establish a link between attention complaints and the begin-
nings of cognitive decline.
Methods
Participant population  
and testing conditions
A total of 975 patients were evaluated in this study, compris-
ing 465 males and 510 females, with an average age of 50.0 
and 51.6 years, respectively. Participants were primarily 
Caucasian, although Black, Asian, and Hispanic participants 
were included as well. These patients were selected from an 
outpatient private clinical practice (medical and neuropsy-
chiatric) and research foundation in New York City, where 
the TOVA is used regularly in the standard cognitive testing 
battery. Two hundred eighty patients who had been screened 
for attention complaints using a modified 16-item checklist 
derived from the DSM-IV diagnostic criteria for ADHD were 
included. These patients may or may not have been screened 
with TOVA and/or WMS-III. Additionally, patients with 
WMS-III and/or TOVA results were included in the study. In 
total, 344 females with TOVA results were included, as well 
as 324 with WMS-III results. One hundred and fifty-eight 
females had both WMS-III and TOVA results for a total of 
510 females included. Three hundred and twelve males with 
TOVA results, as well as 310 with WMS-III results, were 
included. One hundred and fifty-seven males had both TOVA 
and WMS-III results for a total of 465 males included.
Patients were made aware that their results would be 
kept confidential and signed consent forms approved by the 
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institution review board for participation in this study were 
obtained. All subjects were part of an ongoing study involv-
ing brain electrical activity mapping and aging research, 
which received institutional review board and ethics board 
approval from the PATH Foundation. Psychometric techni-
cians trained inWMS-III and TOVA administration and inter-
pretation via tutorial conducted the tests. All test interpreters 
were blinded to other patient results.
TOVA measurement
This study assessed 656 patients with TOVA data between 
40 and 89 years of age. The TOVA was developed in the 
1960s, with the current version Number 7 being released 
in 1997. The TOVA is an age- and gender-normalized17 
computer-based assessment of inattention, approximately 
21.6 minutes in duration. Its lengthy run allows it to mea-
sure attention deficits effectively. The subject is situated 
in front of a computer screen where a flashing square is 
presented for 1/10th of a second in two-second intervals. 
The square will flash in either the top portion of a larger 
square or it will be presented in the bottom portion of the 
square. If the small box appears on the top, it is labeled 
as the target and, if at the bottom, it is labeled as the 
nontarget. Each time the target box appears, the person 
is instructed to press a small microswitch as soon as they 
see the target. Every time the nontarget box appears, the 
person is instructed to refrain from pressing the micro-
switch. Omission errors signify the number of times the 
patient failed to click the microswitch when the target was 
presented. Commission errors signify the number of times 
the patient clicked the microswitch at the incorrect time, 
(ie, “jumped the gun”). Response time is the amount of 
time it took the patient to press the microswitch when the 
target was presented. Variability is the consistency of the 
patient’s response times.
In order for a score in any of the four measurement 
categories to be significantly deviant on the TOVA, it must 
be less than -1.33 (ie, 1.33 standard deviations [SD] below 
normal).18,19 We will use the term “significantly deviant 
or borderline” (SDB) on the TOVA to indicate any score 
between -1.00 and -1.33. Subjects scoring above -1.0 were 
considered “normal”.
Memory assessment on Wechsler 
Memory scale
WMS-III is the most widely used standardized measure to 
assess memory abilities. This study assessed 634 patients 
40–89 years of age with WMS-III data. Results are 
organized into summary index scores, reflecting verbal, 
visual, immediate, and working memory, and interpreted 
accordingly. A score of 130 and above demonstrates very 
superior abilities; 120–129 is considered superior; 110–119 
demonstrates high average abilities; 90–109 indicates 
average abilities; an index score of 80–89 is consid-
ered low average; 70–79 indicates borderline abilities; 
and #69 demonstrates memory impairment. These scores 
were standardized based on a sample of 1250 individuals 
aged 16–89 years.2
statistical analysis
Spearman rank correlations were used to check for associa-
tions of the TOVA error subtypes, stratified by age decade 
and correlating with the WMS-III components. Spearman 
correlations that resulted in an r-squared of 0.10 or more 
were considered to have clinical significance.
Comparison of males and females for TOVA scores were 
made by using Mann–Whitney tests, and for clinical measures 
by using Student’s t-tests, with P , 0.05 considered to be 
statistically significant.
For each TOVA error subtype, comparisons using 
unpaired Student’s t-tests (with P , 0.05 considered sig-
nificant) of age and WMS-III were made between subjects 
who had an SD (below -1.33) score versus subjects that 
scored 0 or better. Using this approach, subjects with a 
TOVA quarter (that is, a quarter of the duration of the 
test during which a particular score is observed in any of 
the four error subtypes) that produced a “marginal” score 
(below 0 but not significantly deviant in any of the four 
error subtypes) were excluded so that comparisons of 
impaired versus normal subjects as defined by the TOVA 
quarter score could be performed. Partial age-controlled 
correlations between the number of ADD complaints in 
self report assessments, TOVA, and WMS-III scores, were 
performed.20
TOVA and WMs-iii scores
This analysis was performed separately for males and females 
aged 40–89 years. Unpaired Student’s t-tests were performed 
to check for differences between SDBs and normals for each 
TOVA quarter, comparing scores for each of the four WMS-
III index measures. Also, WMS-III scores were classified as 
“impaired” (, 80) versus “normal” (. 99) so that Chi-square 
tests could be performed. Finally, the total number of SDB 
TOVA quarters was calculated. Partial correlations between 
the number of SDB quarters and WMS-III scores, control-
ling for age, were performed, and logistic regression was 
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performed to determine if the number of SDB quarters was 
a significant predictor for WMS-III “impaired” or “normal” 
group membership. Also, one-way analyses of variance 
(ANOVAs) with post hoc Bonferroni-adjusted Student’s 
t-tests were performed to check if the means of WMS-III 
scores were significantly different for the total number of 
SDB TOVA quarters.
Attention deficit disorder complaints and TOVA
This analysis was performed separately for males and 
females aged 40–89 years. Mann–Whitney U tests compar-
ing the number of ADD complaints for SDBs versus normals 
for each TOVA quarter were performed. Also, the correlation 
between the number of SDB TOVA quarters and the number 
of ADD complaints controlling for age was calculated.
Attention deficit disorder complaints  
and WMs-iii index scores
This analysis was performed separately for males and females 
aged 40–89 years. Partial correlations between the number 
of ADD complaints and WMS-III scores controlling for age 
were performed. Also, Mann–Whitney U tests comparing the 
number of ADD complaints for “impaired” versus “normal” 
for each WMS-III component were performed.
Results
TOVA and WMs-iii scores
Males
Of 157 males with both TOVA and WMS-III data, the 
means for auditory, visual, immediate, and working mem-
ory scores were significantly greater for normals versus 
SDBs for omission errors (P , 0.010) and response time 
(P , 0.050). The mean scores for auditory, visual, and 
immediate memory scales were significantly greater for 
normals versus SDBs for variability (P , 0.045). No sig-
nificant differences among WMS-III scores were observed 
for normals versus SDBs for commission errors (P . 0.30, 
Table 1, Figures 1 and 2).
The Chi-square results generally reflected the t-test 
results. For example, males who were SDB for omission 
subtests were more likely than normals to be classified as 
“impaired” on the auditory, visual, immediate, and working 
memory sections of the WMS-III (P , 0.001). The number 
of SDB TOVA quarters (or quarters of the duration of the 
test during which SDB TOVA errors were observed) was sig-
nificantly correlated with auditory (r = -0.224, P , 0.005), 
visual (r = -0.269, P , 0.001), compiling immediate memory 
ability (r = -0.275, P , 0.001), as well as with the working 
memory subtest (r = -0.205, P , 0.010) groups (Figure 3).
Table 1 Wechsler Memory scale data
Age group Female Male
Subjects (n) Mean Standard deviation Subjects (n) Mean Standard deviation
Auditory
40–49 69 102.03 19.96 89 101.15 17.5
50–59 89 106.82 19.26 67 103.4 18.24
60–69 69 102.09 19.21 66 100.21 19.1
70–93 99 92.71 20.51 88 94.69 20.27
Total 326 100.52 20.45 310 99.6 19.01
Visual 
40–49 69 100.03 18.23 89 96.17 17.63
50–59 89 104.4 20.28 67 96.24 20.69
60–69 69 96.1 18.91 66 90.95 17.43
70–93 98 89.98 20.38 89 85.38 19.05
Total 325 97.36 20.32 311 91.99 19.18
Immediate memory
40–49 69 99.16 22.01 89 98.9 20.5
50–59 89 106.37 21.95 67 100.31 18.91
60–69 69 99.43 26.24 66 95.89 20.01
70–93 99 89.34 22.19 89 88.6 19.88
Total 326 98.21 23.81 311 95.62 20.34
Working memory
40–49 69 94.68 16.79 89 96.66 13.73
50–59 88 94.73 17.16 67 97.07 20.69
60–69 69 90.39 14.96 65 96.46 15.01
70–93 98 90.1 19.07 89 90.64 15.61
Total 324 92.4 17.32 310 94.98 16.4
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Figure 1 Weschler Memory scale comparisons across test of variables of attention (TOVA) outcome in males.
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Figure 2 Classification of Weschler memory impairment across test of variables of attention (TOVA) outcome in males.
Neuropsychiatric Disease and Treatment 2010:6submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
686
Braverman et al
Females
Of 158 females with both WMS-III and TOVA data, the means 
for visual and working memory scores were significantly 
greater for normals versus SDBs for omissions (P , 0.025). 
Also, females who were SDB for omission were more likely 
to be classified as “impaired” for visual memory (P , 0.010) 
than normals, and females who were SDB for commission 
errors were more likely to be classified as “impaired” for 
visual (P , 0.035) and immediate memory (P , 0.045) than 
normals. No other significant differences were observed for 
females (P . 0.05, Table 1, Figures 4 and 5).
The number of SDB TOVA quarters was not significantly 
correlated with any of the WMS-III components, and all 
r-squares were less than 0.02 (P . 0.08).
Attention deficit disorder  
complaints and TOVA
Of 280 patients evaluated, 63.2% reported attention com-
plaints as measured by self report checklists designed using 
the DSM-IV diagnostic criteria for ADD and ADHD, and 
38.6% reported four or more complaints out of 16 (Table 3). 
Therefore, we decided to utilize this population to determine 
whether there were associations with ADD complaints, 
TOVA quarters and subtests, and WMS-III index scores.
For the 128 males with a recorded number of ADD 
complaints, SDBs had a significantly greater number of 
ADD complaints compared with normals for omissions 
(P , 0.020), response time (P , 0.015), and variability 
(P , 0.005), but not commissions (P . 0.50). The partial 
correlation between the number of ADD complaints and 
the number of SDB TOVA quarters was also significant 
(r = 0.251, P , 0.005). For the 152 females with a recorded 
number of ADD complaints, no significant differences 
between SDBs and normals were observed (P . 0.15). The 
partial correlation between the number of ADD complaints 
and the number of SDB TOVA quarters was also not signifi-
cant, with r-squares less than 0.02 (P . 0.15) (Figure 6).
Number of attention  
complaints and WMs-iii
Of the 78 males with attention complaints and WMS-III 
data, no significant partial correlations were observed 
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Figure 3 Weschler Memory Scale comparisons across number of significantly deviant or borderline test of variables of attention (TOVA) quarters in males.
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Figure 4 Weschler Memory scale comparisons across test of variables of attention (TOVA) outcome in females.
Table 2 TOVA data: TOVA Quarter Significantly Deviant or Borderline (SDB)
Gender Age by Decade  Omission Commissions Response Time Variability 
Females 40–49 % sDB 30.30% 16.16% 12.12% 41.41%
with TOVA data 99 99 99 99
with sDB TOVA 30 16 12 41
50–59 % sDB 31.91% 19.15% 11.70% 46.81%
with TOVA data 94 94 94 94
with sDB TOVA 30 18 11 44
60–69 % sDB 33.33% 19.05% 15.87% 36.51%
with TOVA data 63 63 63 63
with sDB TOVA 21 12 10 23
70–93 % sDB 32.95% 23.86% 22.73% 42.05%
with TOVA data 88 88 88 88
with sDB TOVA 29 21 20 37
Total % sDB 31.98% 19.48% 15.41% 42.15%
with TOVA data 344 344 344 344
with sDB TOVA 110 67 53 145
Males 40–49 % sDB 20.95% 20.95% 31.43% 51.43%
with TOVA data 105 105 105 105
with sDB TOVA 22 22 33 54
50–59 % sDB 28.40% 29.63% 8.64% 48.15%
with TOVA data 81 81 81 81
with sDB TOVA 23 24 7 39
60–69 % sDB 35.59% 32.20% 13.56% 33.90%
with TOVA data 59 59 59 59
with sDB TOVA 21 19 8 20
70–93 % sDB 28.36% 17.91% 11.94% 26.87%
with TOVA data 67 67 67 67
with sDB TOVA 19 12 8 18
Total % sDB 27.24% 24.68% 17.95% 41.99%
with TOVA data 312 312 312 312
with sDB TOVA 85 77 56 131
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Figure 5 Classification of Weschler memory impairment across test of variables of attention (TOVA) outcome in females.
Abbreviation: sDB, significantly deviant or borderline
Table 3 Attention complaint data
Age None Mild 1–3 Moderate 4–6 Severe $7 Total
Females
40–49 12 (26.7%) 15 (33.3%) 9 (20.0%) 9 (20.0%) 45
50–59 19 (40.4%) 9 (19.1%) 8 (17.0%) 11 (23.4%) 47
60–69 9 (36.0%) 11 (44.0%) 3 (12.0%) 2 (8.0%) 25
70–93 25 (71.4%) 5 (14.3%) 2 (5.7%) 3 (8.6%) 35
All ages 65 (42.8%) 40 (26.3%) 22 (14.5%) 25 (16.4%) 152
Males
40–49 11 (22.0%) 10 (20.0%) 14 (28.0%) 15 (30.0%) 50
50–59 6 (16.7%) 10 (27.8%) 9 (25.0%) 11 (30.6%) 36
60–69 9 (47.4%) 3 (15.8%) 6 (31.6%) 1 (5.3%) 19
70–93 12 (52.2%) 6 (26.1%) 2 (8.7%) 3 (13.0%) 23
All ages 38 (29.7%) 29 (22.7%) 31 (24.2%) 30 (23.4%) 128
between the number of ADD complaints reported 
for WMS-III scores, with all r-squares less than 0.02 
(P . 0.35). The number of ADD complaints reported was 
not significantly different for “impaired” versus “normal” 
for any of the four WMS-III components (P . 0.70). Of the 
68 females with data for both measures, no significant 
partial correlations were observed between the number 
of ADD complaints reported or WMS-III scores, with all 
r-squares less than 0.05 (P . 0.070). The number of ADD 
complaints reported was not significantly different for 
“impaired” versus “normal” for any of the four WMS-III 
components (P . 0.40, Table 3).
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Discussion
In a previous paper, Braverman and Blum19 evaluating 1506 
subjects (71% Caucasian, 21% Black, 7% Hispanic, and less 
than 1% Asian) found that the P300 latency event-related 
potential was an accurate predictor of cognitive decline. They 
further went on to show that increased P300 latency has a 
positive association with decreased attentional processing as 
measured by TOVA. In the present study we took the concept 
of early detection to another important level, ie, correlating 
attentional processing with the standard subjective measures 
of attention disorders (complaints) and memory function as 
measured by WMS-III.
We found no reliable connection between ADD and 
WMS-III complaints. However, decreased TOVA perfor-
mance correlated more reliably with both WMS-III and ADD 
complaints (more obvious in males than in females). Thus, 
our findings seem to indicate that involvement of the TOVA 
in ADD diagnostics leads to a more accurate description of 
specific impairments experienced by the patient.
Genetic studies appear to confirm our associations of 
memory function and TOVA results. While many genes are 
involved in ADHD, the etiology involves dopamine function. 
Stimulants, such as methylphenidate, seem to calm ADHD 
patients by indirectly influencing the dopaminergic system 
(DRD2, DRD3, and DRD4, among other genes, as men-
tioned earlier).21–23 Interestingly, the DRD4 exon III repeat 
region has been shown to have a significant correlation with 
TOVA results. Patients with this DRD4 exon III repeat region 
performed poorly on several areas of the TOVA.24 Dopamine 
also seems to play an important role in working memory, 
which is another dimension of attention and was measured 
on the WMS-III.25
Conclusion
Our results suggest that TOVA may be an important screening 
indicator (and more valuable than self report scales) of early 
impaired attentional processing problems, serving as an 
objective rather than a subjective indicator. This may lead to 
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Figure 6 Number of ADD complaints across TOVA outcome in males. Percentages represent the percentage of males in each group having 0, 1–3, 4–6, and ≥ 7 ADD 
complaints for a total of 100% per group. Percentages for males with normal TOVAs are shown in the outer part of the pie cluster, and percentages for males with significantly 
deviant or borderline TOVAs are shown in the inner part of the pie cluster. 
Abbreviations: ADD, attention deficit disorder; SDB, significantly deviant or borderline; TOVA, test of variables of attention.
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a better way to predict attention problems early on, and thus 
develop early intervention methodologies for the prevention 
and treatment of ADHD and other attentional disorders, includ-
ing dementia. Furthermore, the established correlations with 
poor performance on the TOVA (not necessarily accompanied 
by attention complaints) and increased P300 latency, as well 
as decreased memory functions as measured by WMS-III, 
imply that impaired attentional processing may be indicative 
of the beginnings of cognitive decline. Our research supports 
the importance of a multimodal approach to diagnosis and 
evaluation of which specific functions are impaired. Additional 
scientific evidence is required, including genetic/genomic 
determinants in both diagnosis and therapeutic targeting.
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